Efficacy and safety of generic glatiramer acetate Timexon®: results of the 12-month extension of BCD-063-1 international double-blind randomized placebo-controlled clinical study of efficacy and safety of Timexon® in comparison with Copaxone®
Keyword(s):
2006 ◽
Vol 8
(6)
◽
pp. 685-692
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 20
(1)
◽
2019 ◽
Vol 8
(4)
◽
pp. 307-319
◽
2018 ◽
Vol 07
(01)
◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 10
(2)
◽
pp. 279
Keyword(s):
2017 ◽
Vol 5
(1)
◽
pp. 143
2020 ◽
Vol 14
(1)
◽
pp. 69-77
◽
Keyword(s):